Sartorius Stedim North America Inc.

Sartorius Stedim North America Inc., a foreign-owned subsidiary of German multinational Sartorius Aktiengesellschaft, supplies bioreactor systems, automated cell culture equipment, laboratory consumables, analytical instruments, and related field service and maintenance to federal research and development agencies as a prime contractor on full-and-open purchase orders, without SBA set-aside designations.

Sartorius Stedim operates from its headquarters in Bohemia, New York, competing entirely in unrestricted federal procurement and holding no certifications under 8(a), HUBZone, SDVOSB, WOSB, or other set-aside categories. The vendor works as a prime on 98% of its recent awards, with two named sub-awards to Weems Design Studio, Inc. for NIAID Vaccine Research Center operational task orders involving Sartorius equipment decommissioning and maintenance. The company's federal contracting footprint spans 119 awards (117 prime, 2 sub) since 2009, with $13.8 million in combined potential value and $13.2 million obligated (96% realization). Activity peaked at 14 awards in 2023 and 13 in 2024, declining to six in 2025 and four in 2026 year-to-date, with three awards (combined potential value $515 thousand) facing ultimate completion in the next twenty-four months.

Customer concentration sits with biomedical research agencies within the Department of Health and Human Services. The top five customer organizations account for 60% of award count, led by the National Institute of Allergy and Infectious Diseases (15 awards, $5.6 million potential value), the FDA (22 awards, $2.6 million), the National Center for Advancing Translational Sciences (13 awards, $2 million), the NIH Clinical Center (11 awards, $242 thousand), and the National Cancer Institute (10 awards, $254 thousand). On dollar concentration, NIAID and FDA anchor 80% of combined potential value; the USDA Agricultural Research Service's Midwest and Plains areas hold smaller footprints ($403 thousand and $511 thousand respectively). The vendor also holds four task orders under the GSA Multiple Award Schedule. Recent representative work includes a $4.507 million firm fixed-price purchase order from NIAID for two AMBR 250 high-throughput bioreactor systems (September 2024, delivery within sixty-five days); a $548 thousand non-competitive commercial-item service contract from NCATS for preventative maintenance and technical support on three SelecT Compact automated cell culture systems through July 2026 (August 2024, with optional twelve-month renewal); a $395 thousand service and maintenance agreement with NCATS for three CompacT SelecT automated cell culture systems (September 2025, exercising Option 1); and a $307 thousand service contract with the Department of Health and Human Services Plains Area office for Sartorius equipment maintenance in Manhattan, Kansas (September 2026, through September 2029).

Federal procurement awards span bioreactor hardware and components (AMBR 250 and AMBR 15 modular systems, Biostat B dual control units, single-use automated systems), automated cell culture platforms (CompacT SelecT Quartz and Annapurna instruments, Incucyte live cell imaging systems), filtration and separation consumables (Sartocon Slice Hydrosart and PES cassettes, tangential flow filtration instruments), software and analytics (SIMCA perpetual licenses and subscriptions), laboratory reagents and biological products, and field service including preventative maintenance, system installation, relocation, decommissioning, recertification, and HEPA decontamination. The vendor's category concentration reflects analytical laboratory instrument manufacturing (46 awards), electronic and precision equipment repair and maintenance (20 awards combined across two NAICS), and drugs and biologicals (11 awards). PSC coding tracks laboratory equipment and supplies (51 awards) and maintenance, repair, and rebuild of instruments and laboratory equipment (26 awards).

Service Contract Inventory reports $273 thousand in invoiced federal service revenue in FY2024 across one contract-level record with zero FTEs recorded; the SCI dataset shows minimal service-contract footprint above the $150,000 reporting threshold. This reflects the vendor's primary business model as a supplier of equipment, consumables, and field repair services procured as commercial items under simplified acquisition and purchase-order authority, rather than as large-scale labor-based service contracts. The vendor competes predominantly on technical specification, equipment compatibility, sole-source OEM authority (Sartorius holds exclusive rights to service its own equipment on many awards), and Buy American Act waivers where domestic alternatives are unavailable, particularly for bioreactor vessels and specialized consumables.